Trinity Biotech plc held its annual general meeting on September 30, 2025. Shareholders approved the re-appointment of Grant Thornton as statutory auditor and authorized the board of directors to fix the statutory auditors' remuneration. Proposals to reduce the nominal value of each A Ordinary Share and to increase the company's authorised share capital were also approved. Additionally, the authority of the board to allot and issue new shares, including for cash without applying Irish statutory pre-emption rights, was refreshed. Jim Walsh retired from the board of directors and will continue to support the company as a Scientific Advisor.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-25-003447), on September 30, 2025, and is solely responsible for the information contained therein.